United States Drug Enforcement Administration

NEW YORK - Raymond P. Donovan, Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), Audrey Strauss, Acting United States Attorney for the Southern District of New York (SDNY), and Dermot Shea, the Commissioner of the New York City Police Department (NYPD), announced today that Dimitrios LYMBERATOS, the operator of a Queens pharmacy, has been charged with obstruction of justice for arranging for a package containing white powder, later identified as cocaine, to be sent to the home address of a DEA Diversion Investigator who was investigating LYMBERATOS’s pharmacy. LYMBERATOS surrendered to the DEA this morning and will be presented before United States Magistrate Judge Barbara Moses in Manhattan federal court later today.

DEA Special Agent in Charge Raymond P. Donovan said:  “Today’s arrest is another example to the public that pharmacy owners can set out to do harm with ill intent.  One of our own Diversion Investigators was allegedly targeted simply for doing their job, and as such, Mr. Lymberatos’s alleged actions were completely unconscionable.  Thankfully, due to the diligent work of our Tactical Diversion Squads, he will be brought to justice.” 

Acting U.S. Attorney Audrey Strauss said: “When Dimitrios Lymberatos learned his pharmacy was under investigation by the DEA, he allegedly took sinister action against a Diversion Investigator assigned to his case. Lymberatos allegedly sought to interfere with the investigation through intimidation, by sending cocaine to the Investigator’s home, potentially causing physical harm. Lymberatos’ misguided message was received loud and clear – and he now faces the possibility of a lengthy prison term for his potentially harmful attempt to obstruct law enforcement.”

NYPD Commissioner Dermot Shea said: “I want to commend the officers, detectives, federal agents, and prosecutors who worked together to investigate the dangerous acts alleged in these charges.”

According to the allegations in the Complaint unsealed today: LYMBERATOS is the operator of a pharmacy in Queens, New York. Beginning in or about November. 2019, the DEA, led by a DEA Diversion Investigator, conducted an overt regulatory investigation into the pharmacy, which had the effect of delaying the issuance of the pharmacy’s registration to dispense controlled substances. LYMBERATOS responded to the investigation of his pharmacy by taking steps to obstruct the investigation, including hiring a private investigator to obtain the Diversion Investigator’s home address, and then causing to be mailed to the Diversion Investigator’s home a greeting card containing a white powdery substance, which law enforcement later determined to be cocaine. Upon receiving the package with white powder, the Diversion Investigator immediately notified law enforcement, which responded to the scene, and the Diversion Investigator was taken to the hospital for toxicology screening. LYMBERATOS caused the package to be sent to the Diversion Investigator in order to interfere with and obstruct the pending investigation into his pharmacy by threatening the Diversion Investigator, deliberately causing the Diversion Investigator to fear for her physical safety, and seeking to create trouble for the Diversion Investigator by causing her to come into possession of an illegal controlled substance.